Piper Sandler Initiates Coverage On Viking Therapeutics With Overweight Rating, Announces Price Target of $74

Benzinga05:48 ET · Ratings

Piper Sandler Initiates Viking Therapeutics(VKTX.US) With Buy Rating, Announces Target Price $74

Moomoo News05:34 ET · Ratings

Express News | Viking Therapeutics Inc : Piper Sandler Initiates Coverage With Overweight Rating; Price Target $74

Reuters04:16 ET

Viking Therapeutics Stock On Brink Of Death Cross As Weight Loss Hype Loses Momentum

BenzingaNov 29 08:42 ET

Here's Yet Another Reason to Buy Viking Therapeutics Stock Like There's No Tomorrow

Yahoo FinanceNov 28 13:17 ET

Will weight loss drugs be included in the US medical insurance, becoming the strongest "roadblock" for the Trump team?

The "Dual Weight Loss Champions" led the significant rise.

Gelonghui FinanceNov 26 20:45 ET